Impact of alemtuzumab pharmacokinetics on T-cell dynamics, graft-versus-host disease and viral reactivation in patients receiving allogeneic stem cell transplantation with an alemtuzumab-based T-cell-depleted graft-Reference-Cited by-同舟云学术

Impact of alemtuzumab pharmacokinetics on T-cell dynamics, graft-versus-host disease and viral reactivation in patients receiving allogeneic stem cell transplantation with an alemtuzumab-based T-cell-depleted graft

Published:2019-12 Issue: Volume:57 Page:101209
ISSN:0966-3274
Container-title:Transplant Immunology
language:en
Short-container-title:Transplant Immunology

Author:

Loeff Floris C.,van Egmond Esther H.M.,Moes Dirk J.A.R.,Wijnands Charissa,Von Dem Borne Peter A.,Veelken Hendrik,Falkenburg J.H. Frederik,Jedema Inge,Halkes Constantijn J.M.

Funder

Frank Sanderse Stichting

Bontius Stichting

Publisher

Elsevier BV

Subject

Transplantation,Immunology,Immunology and Allergy

Reference44 articles.

1. NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-Tumor/Leukemia Reaction

2. Role of donor lymphocyte infusions in relapsed hematological malignancies after stem cell transplantation revisited;Deol;Cancer Treat. Rev.,2010

3. Donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation;Roddie;Expert. Opin. Biol. Ther.,2011

4. Intentional donor lymphocyte-induced limited acute graft-versus-host disease is essential for long-term survival of relapsed acute myeloid leukemia after allogeneic stem cell transplantation;Eefting;Haematologica.,2014

5. Myeloablative T cell-depleted alloSCT with early sequential prophylactic donor lymphocyte infusion is an efficient and safe post-remission treatment for adult ALL;Eefting;Bone Marrow Transplant.,2014

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-dose alemtuzumab and cyclosporine vs tacrolimus, methotrexate, and sirolimus for chronic graft-versus-host disease prevention;Blood Advances;2024-08-15

2. Early recovery of natural killer cells post T-cell depleted allogeneic stem cell transplantation using alemtuzumab “in the bag”;Transplant Immunology;2024-06

3. Allogeneic Hematopoietic cell Transplantation Using Alemtuzumab in Asian Patients with Inborn Errors of Immunity;Journal of Clinical Immunology;2024-05-22

4. Competitive Repopulation and Allo-Immunologic Pressure Determine Chimerism Kinetics after T Cell-Depleted Allogeneic Stem Cell Transplantation and Donor Lymphocyte Infusion;Transplantation and Cellular Therapy;2023-04

5. Population pharmacokinetics of subcutaneous alemtuzumab in kidney transplantation;British Journal of Clinical Pharmacology;2022-12-09